Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohort

Title: Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohort
Authors: Schaffer, AL; Andrews, CD; Brown, AD; Croker, R; Hulme, WJ; Nab, L; Quinlan, J; Speed, V; Wood, C; Wiedemann, M; Massey, J; Inglesby, P; Bacon, SCJ; Mehrkar, A; Bates, C; Goldacre, B; Walker, AJ; MacKenna, B
Contributors: Collaborative, OpenSAFELY
Publisher Information: Elsevier
Publication Year: 2025
Collection: Oxford University Research Archive (ORA)
Description: BackgroundThe COVID-19 pandemic disrupted health-care delivery, including difficulty accessing in-person care, which could have increased the need for strong pharmacological pain relief. Due to the risks associated with overprescribing of opioids, especially to vulnerable populations, we aimed to quantify changes to measures during the COVID-19 pandemic, overall, and by key subgroups.MethodsFor this interrupted time-series analysis study conducted in England, with National Health Service England approval, we used routine clinical data from more than 20 million general practice adult patients in OpenSAFELY-TPP, which is a a secure software platform for analysis of electronic health records. We included all adults registered with a primary care practice using TPP-SystmOne software. Using interrupted time-series analysis, we quantified prevalent and new opioid prescribing before the COVID-19 pandemic (January, 2018–February, 2020), during the lockdown (March, 2020–March, 2021), and recovery periods (April, 2021–June, 2022), overall and stratified by demographics (age, sex, deprivation, ethnicity, and geographical region) and in people in care homes identified via an address-matching algorithm.FindingsThere was little change in prevalent prescribing during the pandemic, except for a temporary increase in March, 2020. We observed a 9·8% (95% CI –14·5 to –6·5) reduction in new opioid prescribing from March, 2020, with a levelling of the downward trend, and rebounding slightly after April, 2021 (4·1%, 95% CI –0·9 to 9·4). Opioid prescribing rates varied by demographics, but we found a reduction in new prescribing for all subgroups except people aged 80 years or older. Among care home residents, in April, 2020, parenteral opioid prescribing increased by 186·3% (153·1 to 223·9).InterpretationOpioid prescribing increased temporarily among older people and care home residents, likely reflecting use to treat end-of-life COVID-19 symptoms. Despite vulnerable populations being more affected by health-care disruptions, ...
Document Type: article in journal/newspaper
Language: English
DOI: 10.1016/s2468-2667(24)00100-2
Availability: https://doi.org/10.1016/s2468-2667(24)00100-2; https://ora.ox.ac.uk/objects/uuid:1041848c-495d-4f5c-9185-dd79476100cf
Rights: info:eu-repo/semantics/openAccess ; CC Attribution (CC BY)
Accession Number: edsbas.7E291BD7
Database: BASE